Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • mpa92643@lemmy.world
    link
    fedilink
    English
    arrow-up
    11
    ·
    edit-2
    1 year ago

    They’re grasping at straws. A majority of this court already ruled that Medicare has the right to compel vaccine mandates on providers who want Medicare reimbursements because Medicare has no obligation to do business with companies/providers that do not meet their rules. The Medicare statute is very clear here.

    These companies are actually arguing that the government requiring negotiations violates their “free speech” to set their own prices and is “depriving them of life, liberty, or property” by not buying from them if they don’t negotiate. The reality is that what they’re asking the court to do is to compel the federal government to buy their products at the price they want to sell them at. The inevitable result of such an outcome is that they can charge 100x what they do now and there’s nothing the government could do but spend 100x as much. When it’s put like that, it’s clear how absurd their argument is.

    • dohpaz42@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      1 year ago

      That makes sense. I worry that with how the courts are today, that they (Big Pharma) might win and - as you said - be able to charge even more for drugs, and there’s nothing anyone can do but pay it.